OTCMKTS:GNGBY Getinge AB (publ) - GNGBY Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Getinge AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. $23.14 -0.25 (-1.07%) (As of 03/28/2023 12:00 AM ET) Add Compare Share Share Today's Range$23.02▼$23.1750-Day Range$20.26▼$24.8452-Week Range$15.87▼$41.54Volume11,133 shsAverage Volume7,578 shsMarket Capitalization$6.30 billionP/E Ratio25.71Dividend Yield1.30%Price TargetN/A ProfileAnalyst RatingsChartCompetitorsDividendEarningsHeadlinesShort Interest About Getinge AB (publ) (OTCMKTS:GNGBY) StockGetinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. It offers products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. The firm operates through the following segments: Acute Care Therapies, Life Science and Surgical Workflows. The Acute Care Therapies segment offers solutions for life support in acute health conditions. The Life Science segment offers a comprehensive range of equipment, technical expertise and consultation to prevent contamination in biopharmaceutical production, biomedical research, medical device manufacturing and laboratory applications. The Surgical Workflows segment offers products and services for efficient disinfection and sterilization of instruments used in operations, operating tables and other high-quality hardware for operating rooms and advanced IT systems for efficient and secure hospital workflows. The company was founded by Olander Larsson in 1904 and is headquartered in Gothenburg, Sweden.Read More Receive GNGBY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Getinge AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Email Address GNGBY Stock News HeadlinesMarch 24, 2023 | finance.yahoo.comGetinge recieves FDA premarket approval for the iCast™ covered stent system in the USMarch 17, 2023 | finance.yahoo.comUS FDA classifies recall of heart devices by Getinge as most seriousMarch 29, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.January 27, 2023 | reuters.comFDA classifies recall of Getinge's heart devices as most seriousJanuary 25, 2023 | finance.yahoo.comUPDATE 1-FDA classifies recall of Getinge's heart devices as most seriousDecember 19, 2022 | finance.yahoo.comINSIGHT-Medical device makers drop products as EU law sows chaosSeptember 22, 2022 | seekingalpha.comGNGBY Getinge AB (publ)July 19, 2022 | seekingalpha.comGetinge AB (GNGBF) CEO Mattias Perjos on Q2 2022 Results - Earnings Call TranscriptMarch 29, 2023 | Weiss Ratings (Ad)Bank Accounts: Frozen!In 1990, the Brazilian government froze the bank accounts of thousands of citizens. In 2013, the victims were the people of Cyprus. In 2022, it hit closer to home — in Canada. And now the Federal Reserve System Docket No. OP-1670 reveals the plan to give the Fed the power to track and potentially even control your checking account. Not just the money you have in your account … But also, every single check, withdrawal, deposit and transaction. Practically everything you do with your money!April 26, 2022 | seekingalpha.comGetinge AB (publ) Non-GAAP EPS of SEK 2.11, revenue of SEK 6.18BApril 26, 2022 | finance.yahoo.comGetinge Interim Report January-March 2022: Healthy order book but supply chain challengesJanuary 28, 2022 | finance.yahoo.comGetinge Year End Report 2021: "Healthy order growth, improved EBITA margin and strong cash flow"January 27, 2022 | tmcnet.comGetinge Launches State-of-the-Art Experience Center in New Jersey to Showcase Innovations in Healthcare and Medical TechnologyJanuary 19, 2022 | uk.finance.yahoo.comGetinge appoints Elin Frostehav as President Acute Care Therapies and Eric Honroth as President Life ScienceOctober 22, 2021 | seekingalpha.comGetinge AB's (GNGBF) CEO Mattias Perjos on Q3 2021 Results - Earnings Call TranscriptOctober 20, 2021 | finance.yahoo.comGetinge Q3 Report 2021: "Strong order intake and our remediation measures completed in Germany"October 20, 2021 | seekingalpha.comGetinge AB 2021 Q3 - Results - Earnings Call PresentationAugust 21, 2021 | barrons.comGetinge AB ADRAugust 20, 2021 | finance.yahoo.comHere's What Could Help GETINGE AB (GNGBY) Maintain Its Recent Price StrengthAugust 3, 2021 | finance.yahoo.comGetinge Joins AdvaMed, Reinforcing Global Commitment to Advancing Innovation in Medical Technology and Improving Healthcare Policy and Patient OutcomesJuly 27, 2021 | finance.yahoo.comGETINGE AB (GNGBY) is on the Move, Here's Why the Trend Could be SustainableJuly 16, 2021 | seekingalpha.comGetinge AB reports Q2 resultsJuly 16, 2021 | seekingalpha.comGetinge AB 2021 Q2 - Results - Earnings Call PresentationJune 4, 2021 | finance.yahoo.comGetinge grows with social fundingMay 6, 2021 | stocknews.com4 of the Best Stocks to Add to Your Portfolio Right NowApril 22, 2021 | finance.yahoo.comGetinge receives US FDA 510(k) clearance for three products, expanding the Servo ventilator platformApril 18, 2021 | markets.businessinsider.comGetinge AB is about to announce its earnings — here's what Wall Street expectsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive GNGBY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Getinge AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Email Address GNGBY Company Calendar Last Earnings2/01/2023Today3/29/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:GNGBY CUSIPN/A CIKN/A Webwww.getinge.com Phone(610) 335-0000Fax46-1-033-556-40Employees10,700Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.90 Trailing P/E Ratio25.71 Forward P/E RatioN/A P/E GrowthN/ANet Income$246.86 million Net Margins8.83% Pretax Margin12.27% Return on Equity10.07% Return on Assets5.91% Debt Debt-to-Equity Ratio0.15 Current Ratio1.44 Quick Ratio0.97 Sales & Book Value Annual Sales$2.81 billion Price / Sales2.25 Cash Flow$1.81 per share Price / Cash Flow12.78 Book Value$11.08 per share Price / Book2.09Miscellaneous Outstanding Shares272,370,000Free FloatN/AMarket Cap$6.30 billion OptionableNot Optionable Beta1.26 Key ExecutivesMattias Sven PerjosPresident, Chief Executive Officer & DirectorLars SandströmChief Financial OfficerAnna RombergExecutive VP-Legal, Compliance & GovernanceCarsten BleckerChief Commercial OfficerJens ViebkePresident-Acute Care Therapies BusinessKey CompetitorsMasimoNASDAQ:MASICONMEDNYSE:CNMDInModeNASDAQ:INMDIntegerNYSE:ITGRTransMedics GroupNASDAQ:TMDXView All Competitors GNGBY Stock - Frequently Asked Questions Should I buy or sell Getinge AB (publ) stock right now? 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Getinge AB (publ) in the last twelve months. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" GNGBY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GNGBY, but not buy additional shares or sell existing shares. View GNGBY analyst ratings or view top-rated stocks. How have GNGBY shares performed in 2023? Getinge AB (publ)'s stock was trading at $20.62 at the beginning of the year. Since then, GNGBY stock has increased by 12.2% and is now trading at $23.14. View the best growth stocks for 2023 here. Are investors shorting Getinge AB (publ)? Getinge AB (publ) saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 100 shares, a drop of 96.6% from the February 28th total of 2,900 shares. Based on an average trading volume of 15,700 shares, the days-to-cover ratio is currently 0.0 days. View Getinge AB (publ)'s Short Interest. How were Getinge AB (publ)'s earnings last quarter? Getinge AB (publ) (OTCMKTS:GNGBY) issued its quarterly earnings data on Wednesday, February, 1st. The company reported $0.31 earnings per share for the quarter. The company earned $793.05 million during the quarter. Getinge AB (publ) had a trailing twelve-month return on equity of 10.07% and a net margin of 8.83%. How often does Getinge AB (publ) pay dividends? What is the dividend yield for Getinge AB (publ)? Getinge AB (publ) declared a dividend on Wednesday, April 20th. Shareholders of record on Thursday, April 28th will be given a dividend of $0.3116 per share on Wednesday, May 18th. This represents a dividend yield of 0.85%. The ex-dividend date of this dividend is Wednesday, April 27th. Read our dividend analysis for GNGBY. Is Getinge AB (publ) a good dividend stock? Getinge AB (publ) (OTCMKTS:GNGBY) pays an annual dividend of $0.30 per share and currently has a dividend yield of 1.27%. The dividend payout ratio is 33.33%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for GNGBY. What is Getinge AB (publ)'s stock symbol? Getinge AB (publ) trades on the OTCMKTS under the ticker symbol "GNGBY." How do I buy shares of Getinge AB (publ)? Shares of GNGBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Getinge AB (publ)'s stock price today? One share of GNGBY stock can currently be purchased for approximately $23.14. How much money does Getinge AB (publ) make? Getinge AB (publ) (OTCMKTS:GNGBY) has a market capitalization of $6.30 billion and generates $2.81 billion in revenue each year. The company earns $246.86 million in net income (profit) each year or $0.90 on an earnings per share basis. How many employees does Getinge AB (publ) have? The company employs 10,700 workers across the globe. How can I contact Getinge AB (publ)? Getinge AB (publ)'s mailing address is LINDHOLMSPIREN 7A, GOTHENBURG V7, 41756. The official website for the company is www.getinge.com. The company can be reached via phone at (610) 335-0000, via email at lars.mattsson@getinge.com, or via fax at 46-1-033-556-40. This page (OTCMKTS:GNGBY) was last updated on 3/29/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.